Somatostatin analogs are an invaluable therapeutic option in the diagnosis and treatment of
somatotropinomas, thyrotropinomas, and functioning and non-functioning …

Somatostatin, also known as somatotropin-release inhibitory factor, is a cyclopeptide that
exerts potent inhibitory actions on hormone secretion and neuronal excitability. Its …

This article is the result of the North American Neuroendocrine Tumor Society consensus
conference on the medical management of pancreatic neuroendocrine tumors from July 19 …

This review is based on a presentation given at the Hans Popper Hepatopathology Society
companion meeting at the 2019 United States and Canadian Academy of Pathology Annual …

Simple Summary Pancreatic neuroendocrine tumors (pNETs) are rare, indolent cancers
whose causation is only partly understood. An increasing number of studies have uncovered …

Both somatostatin (SST) and somatostatin receptors (SSTRs) are proteins with important
functions in both physiological tissue and in tumors, particularly in neuroendocrine tumors …

Purpose Neuroendocrine neoplasms can occur as part of inherited disorders, usually in the
form of well-differentiated, slow-growing tumors (NET). The main predisposing syndromes …

Neuroendocrine neoplasms (NENs) are a heterogeneous group of epithelial neoplastic
proliferations that irrespective of their primary site share features of neural and endocrine …

Patients with neuroendocrine tumors (NETs) can be treated with peptide receptor
radionuclide therapy (PRRT). Here, the somatostatin analogue octreotate radiolabeled with …

Neuroendocrine neoplasms (NENs) comprise a heterogeneous group of tumors, mainly
localized in the gastrointestinal system. What characterizes NENs is the expression of …